Abstract
BCG (Bacillus of Calmette-Guérin) immunotherapy has been applied for more than 40 years in non-muscle invasive bladder cancer treatment, although the mechanism of action involved in its antitumor effect is still poorly understood. The therapeutic approach on BCG use is modulate the tumor microenvironment (TME), turning cold tumors in hot tumors. Our research group have demonstrated some i…